Sempraan Is a New Name on a Barrel That Is Still Rolling Downhill

MGP's rebrand, a reaffirmed guide, and a fourth straight quarter of "the plant is fixed" — the equity is down 87% from its peak for reasons the press release cannot rename

MGPI · Earnings Call · 2026-10-28

The name changed; the ledger didn't

On Monday, MGP Ingredients becomes Sempraan, trading on Nasdaq under CASK. Julie Francis sold it as an evolution — from a single distillery in 1941 to three segments — but she also did something rare and useful: she told you exactly what it is not. “our rebrand does not change the 3 reportable segments how we report our results, our 2026 guidance or our leadership team” — Julie Francis, President and CEO · 2026-10-28. Add the launch of "Epic MASH," an internal leadership and values framework, and you have the anatomy of a narrative reset rather than a strategic one. That matters because of where the shares sit. The stock peaked at $125.50 in November 2022 and is down roughly 87% from there; the company is worth about $358 million, and the last 90 days have been essentially flat — down 1.0%, with a July peak of $18.88 and an 11% drawdown from it. At 0.8x trailing revenue, a name change is cheap. What is not cheap is what is underneath it. The quarter itself was a clean beat on the bottom and a miss on the top: sales of $117.9 million fell 10%, but adjusted EBITDA of $21.5 million and adjusted EPS of $0.39 both came in ahead of plan, and full-year guidance was reaffirmed at $480–500 million of sales, $90–98 million of adjusted EBITDA and $1.50–1.80 of adjusted EPS. That combination — miss revenue, beat profit, hold the guide — is the signature of a cost-cutting story, not a growth story. The ownership cost management mindset is doing the work; the demand line is not.

Brown goods broke; white goods paid the bills

Distilling Solutions is where the real information is. Segment sales fell 29% to $29 million, and brown goods sales collapsed 47% as large multinationals stayed on the sidelines. Against that, white goods and co-products grew 32%, warehouse services grew 3% and now represent 29% of segment sales, and sales to ready-to-drink and private label customers are up 90% year to date — more than a quarter of total brown and white goods product sales. Brandon Gall called warehouse services roughly a third of segment revenue, fully contracted and free-cash-flow generative. That is the shock absorber. But the new disclosure that deserves a red pen is on price. For two years management has insisted pricing was under pressure but rational; in the first half of 2026 brown goods volumes fell while price/mix was still a benefit. This quarter, both went negative. Here is Gall, unvarnished:

We have gotten more pointed on our pricing on age. There have been a lot of spot sales at certain points where we... decided to in certain cases price match with the right customers to better align with them and form more of a direct relationship. It is still profitable sales.
Brandon Gall, Chief Financial Officer · 2026-10-28

That is a defensible commercial choice — trading margin for relationship depth in an oversupplied market — and it explains both the better-than-expected brown goods volume and the strong cash generation. It is also the first admission that the price umbrella has folded. The offset is that new distillate visibility is now genuinely thin, as Gall concedes: “that is a lot of new distillate ground goods visibility that we do not have going into next year that we have had historically” — Brandon Gall, Chief Financial Officer · 2026-10-28. Note what quietly disappeared. In April, Francis said plainly, “We continue to view 2026 as likely a trough year for Distilling Solutions.” — Julie Francis, President and CEO · 2026-04-29 Eighteen weeks later the word "trough" is gone, replaced by "increasing confidence in 2027 and beyond" resting on warehouse services, craft spot buying and private label orders booked through the third quarter of next year. That is a softer floor than the April language implied, and the market should treat it as such.

The plant that keeps getting fixed

Ingredient Solutions is the recurring motif. Sales rose 5% to $30.8 million, specialty protein grew 15%, and gross margin was 6.0% — still crushed by waste starch stream costs. Francis was emphatic: “it is not a demand issue. We are fully booked. Every pound, including if we were to get more pounds...” — Julie Francis, President and CEO · 2026-10-28 She then cited three consecutive months at 90% capacity utilization, a level hit only once each in 2024 and 2025. That is a genuine operational improvement. But the framing is a year old almost to the syllable. On the October 2025 call she said, “it's important to note that it's not a commercial demand issue” — Julie Francis, Chief Executive Officer · 2025-10-29 — the same defense, with the same effluent problem, four quarters running. In July she guided to exiting 2027 near a low-20s gross margin; today she concedes lowering waste disposal costs is "taking longer than we expected." The reaffirmed $140–150 million full-year segment range implies something like $40 million-plus of fourth-quarter revenue versus $30.8 million in Q3, a step change that depends entirely on the reliability claim holding.

The balance sheet is the actual story

Strip out the segment color and this is a deleveraging call. Total debt fell $28.4 million in the quarter and the net leverage ratio landed at 3.6x, ahead of plan. But look at the shape underneath: effective net cash of negative $359 million, with liabilities at 44.1% of assets. Free cash flow was deeply negative in the June quarter before rebounding in Q3. Two disclosures deserve more attention than they got. First, the August amendment lets the company “add back up to $20 million of losses on receivables from specified customers in our covenant calculations through the end of 2027” — Brandon Gall, Chief Financial Officer · 2026-10-28 — "precautionary," yes, but a covenant that needs a bespoke receivable add-back is telling you something about the counterparty mix. Second, $201 million of 1.875% convertible notes go to a put on November 16; management expects most or all holders to tender and will fund it through the credit agreement or note purchase agreement, with fourth-quarter interest expense sequentially higher and roughly $12 million for the year. Refinancing a 1.875% coupon in this rate environment is a permanent earnings headwind. The bull case is not absurd: gross margin of 37.4% in the June quarter stepped down to 34.3% in Q3 on waste-starch costs and branded-spirits maintenance, and 50.2% branded-spirits margins remain respectable; core expressions at Penelope grew 35% and the mid-tier portfolio grew 6% as value for money consumers traded into trusted brands. Six of ten core 10 brands are now growing versus one a year ago. The system cutover from ten markets in June plus six in Q3 is a real, finite headwind, and the route to market expansion into beer trucks with a Q1 test is a legitimate option. But the equity at $358 million is not paying for optionality — it is paying roughly 0.8x revenue and 57x depressed net income for a company that has to simultaneously refinance, delever, restart new-distillate demand it cannot see, and deliver a fourth-quarter Ingredient Solutions number it has promised for a year. The rebrand is the least interesting thing on the tape. The covenant add-back is the most.